# ScoreItem: Microalbuminúria/creatininúria – urina amostra isolada

**ID:** `c77cedd3-2800-7cce-9809-9b202222501e`
**FullName:** Microalbuminúria/creatininúria – urina amostra isolada (Exames - Laboratoriais)
**Unit:** mg/g

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 3 artigos
- Avg Similarity: 0.679

---

## Contexto

Você é um especialista em medicina funcional integrativa e está contribuindo com o **Escore Plenya** — um escore completo de análise de saúde que avalia todos os aspectos da saúde, performance e longevidade humana. Cada ScoreItem representa um parâmetro clínico, laboratorial, genético, comportamental ou histórico que compõe esse escore.

Seu papel é gerar conteúdo clínico de alta qualidade para enriquecer cada parâmetro do escore com relevância clínica, orientação ao paciente e conduta prática.

**Regras inegociáveis:**
- Use **apenas** o conhecimento médico real consolidado e os dados presentes nos chunks científicos abaixo
- **Não alucine, não invente** dados, estudos, estatísticas ou referências que não estejam nos chunks ou no seu conhecimento médico estabelecido
- Se um dado específico não constar nos chunks e não for do seu conhecimento consolidado, **não o inclua**
- Seja preciso: prefira omitir a inventar

## Instrução

Com base nos chunks científicos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-7cce-9809-9b202222501e`.**

```json
{
  "score_item_id": "c77cedd3-2800-7cce-9809-9b202222501e",
  "clinical_relevance": "Texto técnico para médicos (1000-5000 chars): definição fisiológica precisa, valores de referência e interpretação, fisiopatologia resumida, dados epidemiológicos com números concretos, estratificação de risco baseada em evidências.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que é este parâmetro sem jargões, por que é importante para a saúde, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta clínica em Markdown (1000-5000 chars): investigação complementar necessária, critérios de encaminhamento a especialistas, intervenções baseadas em evidências. Use bullet points, seções e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto clínico: 1-9 pts
- Alto impacto clínico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Critérios: gravidade/mortalidade (40%), prevalência (30%), intervencionabilidade (30%)

---

### Contexto Científico

**ScoreItem:** Microalbuminúria/creatininúria – urina amostra isolada (Exames - Laboratoriais)
**Unidade:** mg/g

**30 chunks de 3 artigos (avg similarity: 0.679)**

### Chunk 1/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.762

tNZJMed.1992;22:334–337.338.GilbertRE,AkdenizA,JerumsG.Detectionofmicroalbuminuriaindiabeticpatientsbyurinarydipstick.DiabetesResClinPract.1997;35:57–60.339.GrazianiMS,GambaroG,MantovaniL,etal.Diagnosticaccuracyofa
reagentstripforassessingurinaryalbuminexcretioninthegeneralpopulation.NephrolDialTransplant.2008;24:1490–1494.340.GuyM,NewallR,BorzomatoJ,etal.Useofarst-lineurineprotein-to-creatinineratiostriptestonrandomurinestoruleoutproteinuriain
patientswithchronickidneydisease.NephrolDialTransplant.2008;24:1189–1193.341.GuyM,NewallR,BorzomatoJ,etal.Diagnosticaccuracyoftheurinary
albumin:creatinineratiodeterminedbytheCLINITEKMicroalbuminandDCA2000þfortherule-outofalbuminuriainchronickidneydisease.ClinChimActa.2008;399:54–58.342.HasslacherC,MullerP,SchlipfenbacherRL.ResultsofamulticentrestudyforthedeterminationofmicroalbuminuriawithMicral-Test.KlinischesLabor.1995;41:441–447.343.HodelNC,HamadA,ReitherK,etal.Comparisonoftwodifferent
semiquantitativeurinarydipsticktestswithal

---

### Chunk 2/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.740

stClin.2006;58:190–197.328.CroalBL,MutchWJ,ClarkBM,etal.Theclinicalapplicationofaurine
albumin:creatinineratiopoint-of-caredevice.ClinChimActa.2001;307:15–21.329.CurrinSD,GondweMS,MayindiNB,etal.Diagnosticaccuracyof
semiquantitativepointofcareurinealbumintocreatinineratioandurinedipstickanalysisinaprimarycareresourcelimitedsettingin
SouthAfrica.BMCNephrol.2021;22:103.330.DajakM,BonticA,UgnjatovicS,etal.[Evaluationofmethodsforrapidmicroalbuminuriascreeninginkidneydiseasedpatients].SrpArhCelokLek.2012;140:173–178[inSerbian].331.DavidsonMB,BazarganM,BakrisG,etal.ImmunoDip:animproved
screeningmethodformicroalbuminuria.AmJNephrol.2004;24:284–288.332.DavidsonMB,SmileyJF.Relationshipbetweendipstickpositiveproteinuriaandalbumin:creatinineratios.JDiabetesComplications.1999;13:52–55.333.deGrauwWJ,vandeLisdonkEH,vandeHoogenHJ,etal.Screeningfor
microalbuminuriaintype2diabeticpatients:theevaluationofadipsticktestingeneralpractice.DiabetMed.1995;12:657–663.334.FernándezFernándezI,Pá

---

### Chunk 3/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.733

22:369.318.McTaggartMP,NewallRG,HirstJA,etal.Diagnosticaccuracyofpoint-of-
caretestsfordetectingalbuminuria:asystematicreviewandmeta-analysis.AnnInternMed.2014;160:550–557.319.AbitbolC,ZillerueloG,FreundlichM,etal.Quantitationofproteinuriawithurinaryprotein/creatinineratiosandrandomtestingwithdipsticksinnephroticchildren.JPediatr.1990;116:243–247.320.AgardhCD.Anewsemiquantitativerapidtestforscreeningformicroalbuminuria.PracticalDiabetes.1993;10:146–147.321.AgarwalR,PanesarA,LewisRR.Dipstickproteinuria:canitguide
hypertensionmanagement?AmJKidneyDis.2002;39:1190–1195.322.AroraS,LongT,MenchineM.Testcharacteristicsofurinedipstickfor
identifyingrenalinsufciencyinpatientswithdiabetes.WestJEmergMed.2011;12:250–253.323.ChangCC,SuMJ,HoJL,etal.Theefcacyofsemi-quantitativeurineprotein-to-creatinine(P/C)ratioforthedetectionofsignicantproteinuriainurinespecimensinhealthscreeningsettings.Springerplus.2016;5:1791.324.ChoMC,JiM,KimSY,etal.EvaluationoftheURiSCANsupercassetteACRsemiquantita

---

### Chunk 4/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.724

rshallSM,AlbertiKG.Screeningforearlydiabeticnephropathy.AnnClinBiochem.1986;23(Pt2):195–197.290.MillerWG,BrunsDE,HortinGL,etal.Currentissuesinmeasurementandreportingofurinaryalbuminexcretion.ClinChem.2009;55:24–38.291.ChitaliaVC,KothariJ,WellsEJ,etal.Cost-benetanalysisandpredictionof24-hourproteinuriafromthespoturineprotein-creatinineratio.ClinNephrol.2001;55:436–447.292.CoteAM,BrownMA,LamE,etal.Diagnosticaccuracyofurinaryspotprotein:creatinineratioforproteinuriainhypertensivepregnant
women:systematicreview.BMJ.2008;336:1003–1006.293.DysonEH,WillEJ,DavisonAM,etal.Useoftheurinaryproteincreatinine
indextoassessproteinuriainrenaltransplantpatients.NephrolDialTransplant.1992;7:450–452.294.Leanos-MirandaA,Marquez-AcostaJ,Romero-ArauzF,etal.Protein:
creatinineratioinrandomurinesamplesisareliablemarkerof
increased24-hourproteinexcretioninhospitalizedwomenwith
hypertensivedisordersofpregnancy.ClinChem.2007;53:1623–1628.295.LemannJJr,DoumasBT.Proteinuriainhealthanddiseaseassessedby

---

### Chunk 5/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.715

inJapan.OpenForumInfectDis.2018;5:ofy216.381.YangCJ,ChenDP,WenYH,etal.Evaluationthediagnosticaccuracyof
albuminuriadetectioninsemi-quantitativeurinalysis.ClinChimActa.2020;510:177–180.382.KouriT,NokelainenP,PelkonenV,etal.EvaluationoftheARKRAYAUTIONElevenreectometerindetectingmicroalbuminuriawithAUTIONScreenteststripsandproteinuriawithAUTIONSticks10PAstrips.ScandJClinLabInvest.2008;69:52–64.383.NagrebetskyA,JinJ,StevensR,etal.Diagnosticaccuracyofurinedipsticktestinginscreeningformicroalbuminuriaintype2diabetes:acohortstudyinprimarycare.FamPract.2012;30:142–152.384.NahEH,ChoS,KimS,etal.Comparisonofurinealbumin-to-creatinineratio(ACR)betweenACRstriptestandquantitativetestinprediabetesanddiabetes.AnnLabMed.2016;37:28–33.385.ShinJI,ChangAR,GramsME,etal.Albuminuriatestinginhypertensionanddiabetes:anindividual-participantdatameta-analysisinaGlobalConsortium.Hypertension.2021;78:1042–1052.386.PantaloneKM,JiX,KongSX,etal.Unmetneedsandopportunitiesforoptimalmanagementofpatientswithty

---

### Chunk 6/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.713

g.ClinNephrol.1999;51:220–227.366.ParsonsMP,NewmanDJ,NewallRG,etal.Validationofapoint-of-care
assayfortheurinaryalbumin:creatinineratio.ClinChem.1999;45:414–417.367.PendersJ,FiersT,DelangheJR.Quantitativeevaluationofurinalysistest
strips.ClinChem.2002;48:2236–2241.368.PoulsenPL,MogensenCE.Clinicalevaluationofatestforimmediateand
quantitativedeterminationofurinaryalbumin-to-creatinineratio.Abrief
report.DiabetesCare.1998;21:97–98.369.PugiaMJ,LottJA,KajimaJ,etal.Screeningschoolchildrenfor
albuminuria,proteinuriaandoccultbloodwithdipsticks.ClinChemLabMed.1999;37:149–157.370.SakaiN,FuchigamiH,IshizukaT,etal.Relationshipbetweena
urineprotein-to-creatinineratioof150mg/gramcreatinineanddipstickgradeinthehealthcheckup:substantialnumberoffalse-
negativeresultsforchronickidneydisease.TokaiJExpClinMed.2019;44:118–123.371.SalinasM,López-GarrigósM,FloresE,etal.Urinaryalbuminstripassay
asascreeningtesttoreplacequantitativetechnologyincertain
conditions.ClinChemLabMed.2018;57:204–209.

---

### Chunk 7/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.707

inmostCKDs.Useof
urinaryalbuminmeasurementasthepreferredtestforpro-teinuriadetectionwillimprovethesensitivity,quality,andconsistencyofapproachtotheearlydetectionandmanage-
mentofkidneydisease.Commonlyusedreagentstripdevicesmeasuringtotalproteinareinsufcientlysensitiveforthereliabledetectionofproteinuria,donotadjustforurinaryconcentration,andare
onlysemiquantitative.Furthermore,thereisnostandardization
betweenmanufacturers.Theuseofsuchstripsshouldbediscouragedinfavorofquantitativelaboratorymeasurementsofalbuminuriaorproteinuria,orvalidatedpoint-of-carede-
vicesforurinealbumin/ACR(Section1.4).Whenused,reagentstripresultsshouldbeconrmedbylaboratorytesting.Althoughthereferencepointremainstheaccuratelytimed24-hourspecimen,itiswidelyacceptedthatthisisadifcultproceduretocontroleffectivelyandthatinaccuraciesinurinary
collectionmaycontributetoerrorsinestimationofalbuminand/orproteinlosses.Inpractice,untimedurinesamplesareareasonablersttestforascertainmentofalbuminuria.Arstmorningvoidsample

---

### Chunk 8/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** methods | **Similarity:** 0.700

JExpClinMed.2019;44:118–123.371.SalinasM,López-GarrigósM,FloresE,etal.Urinaryalbuminstripassay
asascreeningtesttoreplacequantitativetechnologyincertain
conditions.ClinChemLabMed.2018;57:204–209.372.SaradisPA,RiehleJ,BogojevicZ,etal.Acomparativeevaluationofvariousmethodsformicroalbuminuriascreening.AmJNephrol.2007;28:324–329.373.ShephardMD,BarrattLJ,Simpson-LyttleW.IstheBayerDCA2000
acceptableasascreeninginstrumentfortheearlydetectionofrenal
disease?AnnClinBiochem.1999;36(Pt3):393–394.374.SiednerMJ,GelberAC,RovinBH,etal.Diagnosticaccuracystudyofurinedipstickinrelationto24-hourmeasurementasascreeningtoolforproteinuriainlupusnephritis.JRheumatol.2007;35:84–90.375.SpoorenPF,LekkerkerkerJF,VermesI.Micral-test:aqualitativedipsticktestformicro-albuminuria.DiabetesResClinPract.1992;18:83–87.376.SzymanowiczA,Blanc-BernardE,RocheC,etal.EvaluationofMicralTestforthescreeningofthemicroalbuminuriainpointofcaretesting.Immuno-AnalyseBiologieSpecialisee.2008;23:109–115.377.TiuSC,LeeSS

---

### Chunk 9/30
**Article:** Proteinuria (2023)
**Journal:** StatPearls Publishing
**Section:** abstract | **Similarity:** 0.697

Comprehensive clinical review of proteinuria covering definition, etiology, diagnosis, and management. Proteinuria serves as a marker of kidney damage assisting with diagnosis, prognosis, and therapy. Normal protein excretion is <150 mg/24 hours. Severity categories: nephritic range (150-3,500 mg/24h) and nephrotic range (>3,500 mg/24h). Urine dipstick provides semi-quantitative screening but has important limitations: false-positives with dehydration, alkaline urine, UTI; inability to detect positively charged proteins. UK CKD guidelines define significant proteinuria as UPCR >45 mg/mmol. Quantitative methods (spot UPCR preferred for convenience and reliability, or 24-hour urine collection for accuracy) are indicated when dipstick is positive or proteinuria >1 g/day is suspected. Early detection and quantification are crucial given associations with progressive renal disease and cardiovascular complications.

---

### Chunk 10/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.687

creatinine(P/C)ratioforthedetectionofsignicantproteinuriainurinespecimensinhealthscreeningsettings.Springerplus.2016;5:1791.324.ChoMC,JiM,KimSY,etal.EvaluationoftheURiSCANsupercassetteACRsemiquantitativeurinedipstickformicroalbuminuriascreening.JClinLabAnal.2014;28:281–286.325.CollierG,GreenanMC,BradyJJ,etal.Astudyoftherelationship
betweenalbuminuria,proteinuriaandurinaryreagentstrips.AnnClinBiochem.2009;46:247–249.326.CollinsAC,VincentJ,NewallRG,etal.Anaidtotheearlydetectionand
managementofdiabeticnephropathy:assessmentofanewpointof
caremicroalbuminuriasysteminthediabeticclinic.DiabetMed.2001;18:928–932.327.Cortés-SanabriaL,Martínez-RamírezHR,HernándezJL,etal.Utilityofthe
DipstickMicraltestIIinthescreeningofmicroalbuminuriaofdiabetesmellitustype2andessentialhypertension.RevInvestClin.2006;58:190–197.328.CroalBL,MutchWJ,ClarkBM,etal.Theclinicalapplicationofaurine
albumin:creatinineratiopoint-of-caredevice.ClinChimActa.2001;307:15–21.329.CurrinSD,GondweMS,MayindiNB,etal.D

---

### Chunk 11/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.678

albumindeterminationinpatientswithtype1diabetes.BrazJMedBiolRes.2002;35:337–343.347.KimY,ParkS,KimMH,etal.Canasemi-quantitativemethodreplacethe
currentquantitativemethodfortheannualscreeningofmicroalbuminuriainpatientswithdiabetes?Diagnosticaccuracyandcost-savinganalysisconsideringthepotentialhealthburden.PLoSOne.2020;15:e0227694.348.LeFlochJP,MarreM,RodierM,etal.InterestofClinitekMicroalbumininscreeningformicroalbuminuria:resultsofamulticentrestudyin302diabeticpatients.DiabetesMetab.2001;27:36–39.349.LeongSO,LuiKF,NgWY,etal.Theuseofsemi-quantitativeurinetest-
strip(MicralTest)formicroalbuminuriascreeninginpatientswithdiabetesmellitus.SingaporeMedJ.1998;39:101–103.350.LimD,LeeDY,ChoSH,etal.Diagnosticaccuracyofurinedipstickforproteinuriainolderoutpatients.KidneyResClinPract.2014;33:199–203.351.LimS,YuHJ,LeeS,etal.EvaluationoftheURiSCAN2ACRStripto
estimatetheurinealbumin/creatinineratios.JClinLabAnal.2017;32:e22289.352.LinCJ,ChenHH,PanCF,etal.Thecharacteristicsofnewsemi-
quantit

---

### Chunk 12/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.678

.Diagnosticaccuracyofpoint-of-caretestsfordetectingalbuminuria:a
systematicreviewandmeta-analysis.AnnIntMed.2014;160:550–557.318SoFtablesSupplementaryTableS5SearchdateJuly2022
Citationsscreened/includedstudies2184/65
SupplementaryFigureS5Chapter2RiskassessmentinpeoplewithCKDClinicalquestionArekidneyfailurepredictionequationsgoodpredictorsofprogression,kidneyfailure,orend-stagerenaldisease?PopulationAdults,children,andyoungpeoplewithCKDG1-G5PredictorKidneyfailureriskequations(e.g.,Tangriequation[KidneyFailureRiskEquation])OutcomesPrognosticperformance:Calibration(goodnessofmeasures,e.g.,R2,Brierscore,andHosmer-Lemeshowtest)Discrimination(e.g.,sensitivity/specicity;areaunderthecurve[AUC]fromreceiveroperatingcharacteristic[ROC]andareaunderthereceiveroperatingcharacteristiccurve[AUROC];C-statistic)StudydesignSystematicreview
ExistingsystematicreviewNationalInstituteforHealthandCareExcellence.Evidencereviewforthebestcombinationofmeasurestoidentifyincreasedriskofprogressioninadults,childr

---

### Chunk 13/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.674

 52.361.OlivariusND,MogensenCE.Danishgeneralpractitioners’estimationofurinaryalbuminconcentrationinthedetectionofproteinuriaand
microalbuminuria.BrJGenPract.1995;45:71–73.362.OstaV,NatoliV,DiéguezS.[Evaluationoftworapidtestsforthe
determinationofmicroalbuminuriaandtheurinaryalbumin/creatinine
ratio].AnPediatr(Barc).2003;59:131–137[inSpanish].363.OyaertM,DelangheJR.Semiquantitative,fullyautomatedurineteststrip
analysis.JClinLabAnal.2019;33:e22870.364.ParkerJL,KirmizS,NoyesSL,etal.Reliabilityofurinalysisfor
identicationofproteinuriaisreducedinthepresenceofotherabnormalitiesincludinghighspecicgravityandhematuria.UrolOncol.2020;38:853.e859–853.e915.365.ParsonsM,NewmanDJ,PugiaM,etal.Performanceofareagentstrip
deviceforquantitationoftheurinealbumin:creatinineratioinapoint
ofcaresetting.ClinNephrol.1999;51:220–227.366.ParsonsMP,NewmanDJ,NewallRG,etal.Validationofapoint-of-care
assayfortheurinaryalbumin:creatinineratio.ClinChem.1999;45:414–417.367.PendersJ,FiersT,DelangheJR.Quan

---

### Chunk 14/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.674

anginglistof“atrisk”groups.27TestingforCKDwithoutregardtoagegeneratescontro-versy.Thoseinolderagegroupsexperiencethegreatest
burdenofCKDandarealsoatthehighestriskforcardio-
vascularcomplications.Aswithotherdetectionprogramslike
cancerdetection,CKDdetectioneffortsshouldbeindividu-
alizedbasedontheperson’sgoalsofcareandsuitabilityfortreatment.PracticePoint1.1.1.2:Followingincidentaldetectionofelevatedurinaryalbumin-to-creatinineratio(ACR),he-
maturia,orlowestimatedGFR(eGFR),repeatteststo
conrmpresenceofCKD.ThereisknownbiologicalandanalyticalvariabilityinSCrandinurinealbuminorurineproteinnotrelatedtotheir
propertiesasmarkersofkidneydisease.Inpeoplewithout
riskfactorsforCKD,thereisalowpretestprobabilityforCKD.Thus,anyunexpectedresultsshouldbeveriedbeforediagnosingapersonashavingCKD.InpeoplewithriskfactorsforCKD,thereisahigherprobabilitythattheperson
doeshaveCKDevenwithanunexpectednding.Subsequenttestingshouldbeperformedtoconrmthediagnosisandtocompletetheevaluation,asisrequired.Ti

---

### Chunk 15/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.671

tegyforclinicalinvestigation:novel
usesofdataonbiologicalvariation.ClinChem.1987;33:2034–2038.262.BallantyneFC,GibbonsJ,O’ReillyDS.Urinealbuminshouldreplacetotalproteinfortheassessmentofglomerularproteinuria.AnnClinBiochem.1993;30(Pt1):101–103.263.LambEJ,MacKenzieF,StevensPE.Howshouldproteinuriabedetected
andmeasured?AnnClinBiochem.2009;46:205–217.264.NewmanDJ,ThakkarH,MedcalfEA,etal.Useofurinealbuminmeasurement
asareplacementfortotalprotein.ClinNephrol.1995;43:104–109.265.DawnayA,WilsonAG,LambE,etal.Microalbuminuriainsystemic
sclerosis.AnnRheumDis.1992;51:384–388.266.GrossJL,deAzevedoMJ,SilveiroSP,etal.Diabeticnephropathy:
diagnosis,prevention,andtreatment.DiabetesCare.2005;28:164–176.267.NinomiyaT,PerkovicV,deGalanBE,etal.Albuminuriaandkidney
functionindependentlypredictcardiovascularandrenaloutcomesindiabetes.JAmSocNephrol.2009;20:1813–1821.268.ShihabiZK,KonenJC,O’ConnorML.Albuminuriavsurinarytotalproteinfordetectingchronicrenaldisorders.ClinChem.1991;37:621–624.

---

### Chunk 16/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** results | **Similarity:** 0.668

eneral,all3devicesdemonstratedacceptableaccuracyatlowerlevelsofeGFR(<30ml/minper1.73m2).316Resultsshowedthati-STATandABLdevicesmayhavehigherprobabilitiesofcorrectlyclassifyingpeopleinthesameeGFRcategoriesasthelaboratoryreferencethan
StatSensordevices.Foralbumin,theERTidentiedasystematicreviewpub-lishedin2014,byMcTaggartetal.,318thatevaluatedthediagnosticaccuracyofquantitativeandsemiquantitativeproteinoralbuminurinedipsticktestscomparedwithlaboratory-basedtestsamongpeoplewithsuspectedor
diagnosedCKD.TheERTincludedrelevantstudiesfrom
thisreviewandconductedanupdate.Sixty-vestudies(in66articles)319–344,345–368,369–384eval-uatedtheaccuracyofquantitativeandsemiquantitativepro-
teinoralbumindipsticktestsinageneralpopulationnoton
chapter1www.kidney-international.orgS194KidneyInternational(2024)105(Suppl4S),S117–S314

KRTorreceivingend-of-lifecare.Studiesaddressedthefollowingcriticaloutcomes:measurementbias(n¼1),analyticalvariability(n¼5),analyticalsensitivity(n¼2),andanalyticspeci

---

### Chunk 17/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.664

deGrauwWJ,vandeLisdonkEH,vandeHoogenHJ,etal.Screeningfor
microalbuminuriaintype2diabeticpatients:theevaluationofadipsticktestingeneralpractice.DiabetMed.1995;12:657–663.334.FernándezFernándezI,PáezPintoJM,HermosínBonoT,etal.Rapid
screeningtestevaluationformicroalbuminuriaindiabetesmellitus.ActaDiabetol.1999;35:199–202.335.GaiM,MottaD,GiuntiS,etal.Comparisonbetween24-hproteinuria,urinaryprotein/creatinineratioanddipsticktestinpatientswith
nephropathy:patternsofproteinuriaindipstick-negativepatients.ScandJClinLabInvest.2006;66:299–307.336.GarciaC,BordierL,BurnatP,etal.[Urinarydipsticksmustnotbeusedtodetectdiabetes-inducedincipientnephropathy].PresseMed.2006;35:1117–1121[inFrench].337.GilbertRE,AkdenizA,JerumsG.Semi-quantitativedeterminationof
microalbuminuriabyurinarydipstick.AustNZJMed.1992;22:334–337.338.GilbertRE,AkdenizA,JerumsG.Detectionofmicroalbuminuriaindiabeticpatientsbyurinarydipstick.DiabetesResClinPract.1997;35:57–60.339.GrazianiMS,GambaroG,MantovaniL,etal.Dia

---

### Chunk 18/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.663

d,can
alsobeconrmedwitharstmorningvoid.ThenumericequivalenceofACRinmg/g(mg/mmol)toapproximatelyg/disbasedonthesimpleassumptionthat
creatinineexcretionrate(CER)approximates1gram/d(10
mmol/d).Tobetterestimateurinealbumininindividualswith
creatininegenerationthatisverydifferentfromtheaverage,one
mightconsidermeasuringatimedurinecollectionifthevalue
wouldaffectclinicaldecisions.AswithassessmentofGFRusing
measuredCrCl,usesupervisedurinecollections.Alternatively,equationsareavailablethatestimatecreatininegenerationfrompredictionequationsandthenmultiplythatvaluebytheACRto
computeanestimatedalbuminexcretionrate(AER)thatac-
commodatesthelowerorhigherlevelofCER.299,300Measurementofurinaryalbuminisrecommendedbecauseitisrelativelystandardizedandbecauseitisthesinglemost
importantproteinlostintheurineinmostCKDs.Useof
urinaryalbuminmeasurementasthepreferredtestforpro-teinuriadetectionwillimprovethesensitivity,quality,andconsistencyofapproachtotheearlydetectionandmanage-
mentofkidneydisease.Commonly

---

### Chunk 19/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.661

434.284.KeaneWF,EknoyanG.Proteinuria,albuminuria,risk,assessment,detection,elimination(PARADE):apositionpaperoftheNational
KidneyFoundation.AmJKidneyDis.1999;33:1004–1010.285.ClaudiT,CooperJG.Comparisonofurinaryalbuminexcretionratein
overnighturineandalbumincreatinineratioinspoturineindiabetic
patientsingeneralpractice.ScandJPrimHealthCare.2001;19:247–248.286.GatlingW,KnightC,MulleeMA,etal.Microalbuminuriaindiabetes:apopulationstudyoftheprevalenceandanassessmentofthreescreeningtests.DiabetMed.1988;5:343–347.287.HutchisonAS,O’ReillyDS,MacCuishAC.Albuminexcretionrate,albuminconcentration,andalbumin/creatinineratiocomparedforscreeningdiabeticsforslightalbuminuria.ClinChem.1988;34:2019–2021.288.MarshallSM.Screeningformicroalbuminuria:whichmeasurement?DiabetMed.1991;8:706–711.289.MarshallSM,AlbertiKG.Screeningforearlydiabeticnephropathy.AnnClinBiochem.1986;23(Pt2):195–197.290.MillerWG,BrunsDE,HortinGL,etal.Currentissuesinmeasurementandreportingofurinaryalbuminexcretion.ClinChe

---

### Chunk 20/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** methods | **Similarity:** 0.660

ientswithoutdiabetes.BMJ.1998;316:504–509.298.SaudanPJ,BrownMA,FarrellT,etal.Improvedmethodsofassessingproteinuriainhypertensivepregnancy.BrJObstetGynaecol.1997;104:1159–1164.299.AbdelmalekJA,GansevoortRT,LambersHeerspinkHJ,etal.Estimated
albuminexcretionrateversusurinealbumin-creatinineratioforthe
assessmentofalbuminuria:adiagnosticteststudyfromthe
PreventionofRenalandVascularEndstageDisease(PREVEND)Study.

---

### Chunk 21/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.660

hohavemetabolicdisordersandareonaverylow–proteindiet,acystatinC–basedequationislikelymoreappropriate.1.3EvaluationofalbuminuriaAlbuminuriareferstoabnormallossofalbuminintheurine(urineACR$30mg/gor$3mg/mmol).Albuminisonetypeofplasmaproteinfoundintheurineinnormalsubjectsand
inlargerquantityinpeoplewithkidneydisease.IntheKDIGO
2012ClinicalPracticeGuidelinefortheEvaluationand
ManagementofChronicKidneyDisease,1clinicalterminologywaschangedtofocusonalbuminuriaratherthanproteinuria
asalbuministheprincipalcomponentofurinaryproteininmostkidneydiseases.Epidemiologicdatademonstrateastrongrelationshipbetweenthequantityofurinealbuminwithboth
kidneyandCVDriskandobservedCVDevenatverylow
levels,andassaystomeasurealbuminaremorepreciseand
sensitivethanassaystomeasureurineprotein.Wereferto
albuminuriaorurinealbuminwhendiscussinggeneral
conceptsandwillrefereithertototalprotein,albumin,orother
specicproteinswhendiscussingthatparameterspecically.1.3.1GuidanceforphysiciansandotherhealthcareprovidersPrac

---

### Chunk 22/30
**Article:** Automated urine sediment analyzers underestimate the severity of hematuria in glomerular diseases (2021)
**Journal:** Scientific Reports
**Section:** results | **Similarity:** 0.659

and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area. Pract. Lab. Med. 17, e00139 (2019). 30. aller, T. R. & Wang, L. P. Evaluation of asymptomatic microscopic hematuria in adults. Am. Fam. Phys. 60, 11431152 (1999). 31. Palsson, R., Srivastava, A. & Waikar, S. S. Performance of the automated urinalysis in diagnosis of proliferative glomerulonephritis. Kidney Int. Rep. 4, 723727 (2019). 32. Orlandi, P. F. et al. Hematuria as a risk factor for progression of chronic kidney disease and death: Findings from the chronic renal insuciency cohort (CRIC) study. BMC Nephrol. 19, 150 (2018). 33. Schulman, G. et al. Risk factors for progression of chronic kidney disease in the EPPIC trials and the eect of AST-120. Clin. Exp. Nephrol. 22, 299308 (2018). 34. Mashitani, T. et al.

---

### Chunk 23/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** methods | **Similarity:** 0.657

nsPediatricconsiderations.PracticePoint1.2.4.3:EstimateGFRinchildrenusingvalidatedequationsthathavebeendevelopedorvalidatedincomparablepopulations.1.3Evaluationofalbuminuria1.3.1GuidanceforphysiciansandotherhealthcareprovidersPracticePoint1.3.1.1:Usethefollowingmeasurementsforinitialtestingofalbuminuria(indescendingorderofpref-erence).Inallcases,arstvoidinthemorningmidstreamsampleispreferredinadultsandchildren.(i)urineACR,or(ii)reagentstripurinalysisforalbuminandACRwithautomatedreading.Ifmeasuringurineprotein,usethefollowingmeasurements:(i)urineprotein-to-creatinineratio(PCR),(ii)reagentstripurinalysisfortotalproteinwithautomatedreading,or(iii)reagentstripurinalysisfortotalproteinwithmanualreading.PracticePoint1.3.1.2:Usemoreaccuratemethodswhenalbuminuriaisdetectedusinglessaccuratemethods.Conrmreagentstrippositivealbuminuriaand/orproteinuriabyquantitativelaboratorymea-surementandexpressasaratiotourinecreatininewhereverpossible(i.e.,quantifytheACRorPCRifinitialsemiquantitativetestsar

---

### Chunk 24/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.656

studies,adoublingoftheACRwithina2-yeardurationisassociatedwithanincreasein
theriskofprogressiontokidneyfailureby50%–100%.391,392
Albuminuria categoriesDescription and rangeGFR categories (ml/min/1.73 m2)Description and rangeA1G1≥90G260–89G3a45–59G3b30–44G415–29G5<15Kidney failureSeverely decreasedModerately toseverely decreasedMildly tomoderately decreasedMildly decreasedNormal or highA2A3Normal to mildlyincreasedModeratelyincreasedSeverelyincreased<30 mg/g<3 mg/mmolScreen1Screen1Treat1Treat1Treat3Treat3Treat1Treat2Treat2Treat3Treat3Treat3Treat*3Treat4+Treat*3Treat4+Treat4+Treat4+30–299 mg/g3–29 mg/mmol≥300 mg/g≥30 mg/mmolCKD is classified based on:�Cause (C)�GFR (G)� Albuminuria (A)Low risk (if no other markers of kidney disease, no CKD)Moderately increased riskHigh risk
Very high risk
Figure13|Frequencyofmonitoringglomerularltrationrate(GFR)andalbuminuriainpeoplewithchronickidneydisease(CKD).AlbuminuriaandGFRgridreectstheriskofprogressionbyintensityofcolor

---

### Chunk 25/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.649

99–203.351.LimS,YuHJ,LeeS,etal.EvaluationoftheURiSCAN2ACRStripto
estimatetheurinealbumin/creatinineratios.JClinLabAnal.2017;32:e22289.352.LinCJ,ChenHH,PanCF,etal.Thecharacteristicsofnewsemi-
quantitativemethodfordiagnosingproteinuriabyusingrandomurine
samples.JClinLabAnal.2011;25:14–19.353.LloydMM,KuylJ,vanJaarsveldH.Evaluationofpoint-of-caretestsfor
detectingmicroalbuminuriaindiabeticpatients.SAfrFamPract.2011;53:281–286.354.MarshallSM,ShearingPA,AlbertiKG.Micral-teststripsevaluatedfor
screeningforalbuminuria.ClinChem.1992;38:588–591.355.MasimangoMI,HermansMP,MalembakaEB,etal.Impactofruralversus
urbansettingonkidneymarkers:across-sectionalstudyinSouth-Kivu,
DRCongo.BMCNephrol.2021;22:234.356.MasimangoMI,SumailiEK,JadoulM,etal.Prevalenceof
microalbuminuriaanddiagnosticvalueofdipstickproteinuriain
outpatientsfromHIVclinicsinBukavu,theDemocraticRepublicof
Congo.BMCNephrol.2014;15:146.357.McTaggartMP,PriceCP,PinnockRG,etal.Thediagnosticaccuracyofa
urinealbumin-creatinineratiopoint

---

### Chunk 26/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** discussion | **Similarity:** 0.645

S,CarlinJB,etal.Albuminuria:populationepidemiology
andconcordanceinAustralianchildrenaged11–12yearsandtheirparents.BMJOpen.2019;9:75–84.308.RademacherER,SinaikoAR.Albuminuriainchildren.CurrOpinNephrolHypertens.2009;18:246–251.309.TsiousC,MazarakiA,DimitriadisK,etal.Microalbuminuriainthepaediatricage:currentknowledgeandemergingquestions.ActaPaediatr.2011;100:1180–1184.310.EmmaF,GoldsteinS,BaggaA,etal.PediatricNephrology.8thed.Springer;2022.311.BrinkmanJW,deZeeuwD,DukerJJ,etal.Falselylowurinaryalbuminconcentrationsafterprolongedfrozenstorageofurinesamples.ClinChem.2005;51:2181–2183.312.SacksDB,ArnoldM,BakrisGL,etal.Executivesummary:guidelinesand
recommendationsforlaboratoryanalysisinthediagnosisandmanagementofdiabetesmellitus.ClinChem.2011;57:793–798.313.SeegmillerJC,MillerWG,BachmannLM.Movingtowardstandardizationofurinealbuminmeasurements.EJIFCC.2017;28:258–267.314.NationalInstituteofStandardsandTechnology.CerticationofStandardReferenceMaterial2925RecombinantHumanSerumA

---

### Chunk 27/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.644

ticentrestudyforthedeterminationofmicroalbuminuriawithMicral-Test.KlinischesLabor.1995;41:441–447.343.HodelNC,HamadA,ReitherK,etal.Comparisonoftwodifferent
semiquantitativeurinarydipsticktestswithalbumin-to-creatinineratioforscreeningandclassicationofalbuminuriaaccordingtoKDIGO.Adiagnosticteststudy.Diagnostics(Basel).2021;11:81.

---

### Chunk 28/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.643

diovascularandrenaloutcomesindiabetes.JAmSocNephrol.2009;20:1813–1821.268.ShihabiZK,KonenJC,O’ConnorML.Albuminuriavsurinarytotalproteinfordetectingchronicrenaldisorders.ClinChem.1991;37:621–624.269.MartinH.Laboratorymeasurementofurinealbuminandurinetotalproteininscreeningforproteinuriainchronickidneydisease.ClinBiochemRev.2011;32:97–102.270.WaughJ,BellSC,KilbyM,etal.Effectofconcentrationandbiochemical
assayontheaccuracyofurinedipsticksinhypertensivepregnancies.

---

### Chunk 29/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.643

eatinineexcretionratevariessubstantiallybetweenpeople.ACRorPCRwilloverestimateurinealbuminlossinpeoplewithlowcreatinineexcretionandwillunder-
estimateurinealbuminorproteinlossinpeoplewithvery
highcreatinineexcretion.ThedecisionbypriorguidelineWorkGroupsnottohaveasex-specicthresholdandtouseeasy-to-remembervaluesregardlessofunitsmayalsoleadtosomemisclassication.Onbalance,thecurrentWorkGroupagreeswiththisapproachgiventhecontinuedunderutilizationofurinealbuminintheassessmentofCKD.Itispossiblethatreplacingurinarytotalproteinmeasure-mentwithalbuminmeasurementmaycausenonalbuminuric(effectivelytubularandoverproduction)proteinuriatobe
missed.Thesignicanceofthisissueisthoughttobelowinadults.258–261Inhealth,relativelysmallamountsofalbumin(<30mg/24hours)arelostintheurine.Urinealbuminmeasurement
providesamorespecicandsensitivemeasureofchangesinglomerularpermeabilitythanurinarytotalprotein.262–264Thereisevidencethaturinaryalbuminisamoresensitivetest
toenablethedetectionofglomerularpathologya

---

### Chunk 30/30
**Article:** KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
**Journal:** Kidney International
**Section:** other | **Similarity:** 0.642

:83–87.376.SzymanowiczA,Blanc-BernardE,RocheC,etal.EvaluationofMicralTestforthescreeningofthemicroalbuminuriainpointofcaretesting.Immuno-AnalyseBiologieSpecialisee.2008;23:109–115.377.TiuSC,LeeSS,ChengMW.Comparisonofsixcommercialtechniquesin
themeasurementofmicroalbuminuriaindiabeticpatients.DiabetesCare.1993;16:616–620.378.TsujikawaH,MachiiR,HiratsukaN,etal.[Evaluationofnovelteststripto
measurealbuminandcreatinineinurine].RinshoByori.2005;53:111–117[inJapanese].379.UsuiT,YoshidaY,NishiH,etal.Diagnosticaccuracyofurinedipstickfor
proteinuriacategoryinJapaneseworkers.ClinExpNephrol.2019;24:151–156.380.YanagisawaN,MuramatsuT,KoibuchiT,etal.Prevalenceofchronic
kidneydiseaseandpoordiagnosticaccuracyofdipstickproteinuriainhumanimmunodeciencyvirus-infectedindividuals:amulticenterstudyinJapan.OpenForumInfectDis.2018;5:ofy216.381.YangCJ,ChenDP,WenYH,etal.Evaluationthediagnosticaccuracyof
albuminuriadetectioninsemi-quantitativeurinalysis.ClinChimActa.2020;510:177–180.382.KouriT,Nok

---

